MwanzoDXCM • NASDAQ
add
DexCom Inc
Bei iliyotangulia
$ 61.18
Bei za siku
$ 58.52 - $ 60.95
Bei za mwaka
$ 56.45 - $ 93.24
Thamani ya kampuni katika soko
23.18B USD
Wastani wa hisa zilizouzwa
6.29M
Uwiano wa bei na mapato
33.52
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.21B | 21.64% |
Matumizi ya uendeshaji wa biashara | 488.90M | 10.66% |
Mapato halisi | 283.80M | 110.85% |
Kiwango cha faida halisi | 23.47 | 73.34% |
Mapato kwa kila hisa | 0.61 | 35.56% |
EBITDA | 306.10M | 47.66% |
Asilimia ya kodi ya mapato | 19.44% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 3.32B | 33.29% |
Jumla ya mali | 7.50B | 18.04% |
Jumla ya dhima | 4.77B | 9.12% |
Jumla ya hisa | 2.73B | — |
hisa zilizosalia | 390.02M | — |
Uwiano wa bei na thamani | 8.75 | — |
Faida inayotokana na mali | 8.18% | — |
Faida inayotokana mtaji | 11.60% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 283.80M | 110.85% |
Pesa kutokana na shughuli | 659.90M | 230.78% |
Pesa kutokana na uwekezaji | 192.80M | -8.32% |
Pesa kutokana na ufadhili | -175.00M | 76.24% |
Mabadiliko halisi ya pesa taslimu | 676.60M | 312.70% |
Mtiririko huru wa pesa | 406.62M | 740.79% |
Kuhusu
Dexcom, Inc. is an American healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1999
Makao Makuu
Tovuti
Wafanyakazi
10,250
